Antonio Cozzio

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi request reprint Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma
    Antonio Cozzio
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Leuk Lymphoma 47:865-9. 2006
  2. ncbi request reprint Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity?
    Antonio Cozzio
    Department of Dermatology, University Hospital of Zurich, Switzerland
    J Am Acad Dermatol 51:1014-7. 2004
  3. ncbi request reprint Cutaneous malignant lymphomas: update 2006
    Gunter Burg
    Dept of Dermatology, University Hospital, Zurich, Switzerland
    J Dtsch Dermatol Ges 4:914-33. 2006
  4. ncbi request reprint Recent advances in cutaneous lymphomas
    Reinhard Dummer
    Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, CH 8091 Zurich, Switzerland
    J Dermatol Sci 48:157-67. 2007
  5. doi request reprint Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012
    Reinhard Dummer
    Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland
    J Clin Oncol 30:4091-7. 2012
  6. ncbi request reprint Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fun
    Philippa Golling
    Department of Dermatology, Cutaneous Lymphoma Study Group, University Hospital, Zurich, Switzerland
    Leuk Lymphoma 49:1094-103. 2008
  7. ncbi request reprint Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?
    Reinhard Dummer
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Exp Dermatol 15:392-400. 2006
  8. ncbi request reprint WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects
    Gunter Burg
    Department of Dermatology, University Hospital Zurich, Switzerland
    J Cutan Pathol 32:647-74. 2005
  9. ncbi request reprint CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype
    Mirjana Urosevic
    Department of Dermatology, University Hospital Zurich, Zurich 8091, Switzerland
    Hum Pathol 36:1020-4. 2005
  10. ncbi request reprint Granulomatous slack skin responds to UVA1 phototherapy
    Patrick A Oberholzer
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Dermatology 219:268-71. 2009

Detail Information

Publications29

  1. ncbi request reprint Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma
    Antonio Cozzio
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Leuk Lymphoma 47:865-9. 2006
    ..All other patients remained free of disease. Thus, intra-lesional IFNalpha2a may represent a valuable alternative to surgery and radiotherapy as first-line treatment of pcMZL...
  2. ncbi request reprint Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity?
    Antonio Cozzio
    Department of Dermatology, University Hospital of Zurich, Switzerland
    J Am Acad Dermatol 51:1014-7. 2004
    ..Here, we report two cases of FUMHD with monoclonal T-cell population, as detected by Southern blot analysis. We propose that clonal FUMHD represents a cutaneous T-cell lymphoma entity...
  3. ncbi request reprint Cutaneous malignant lymphomas: update 2006
    Gunter Burg
    Dept of Dermatology, University Hospital, Zurich, Switzerland
    J Dtsch Dermatol Ges 4:914-33. 2006
    ..Besides the classical options for therapy, there are new and "experimental" strategies, the efficacy of which has to be studied in clinical trials...
  4. ncbi request reprint Recent advances in cutaneous lymphomas
    Reinhard Dummer
    Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, CH 8091 Zurich, Switzerland
    J Dermatol Sci 48:157-67. 2007
    ....
  5. doi request reprint Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012
    Reinhard Dummer
    Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland
    J Clin Oncol 30:4091-7. 2012
    ..There is a need for multicenter trials involving defined patient populations using rigorous assessment criteria. We have investigated pegylated liposomal doxorubicin (PLD) in a clearly defined patient population with advanced MF...
  6. ncbi request reprint Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fun
    Philippa Golling
    Department of Dermatology, Cutaneous Lymphoma Study Group, University Hospital, Zurich, Switzerland
    Leuk Lymphoma 49:1094-103. 2008
    ..Surgical excision or radiotherapy is highly effective in pcMZL and pcFCL...
  7. ncbi request reprint Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?
    Reinhard Dummer
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Exp Dermatol 15:392-400. 2006
    ....
  8. ncbi request reprint WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects
    Gunter Burg
    Department of Dermatology, University Hospital Zurich, Switzerland
    J Cutan Pathol 32:647-74. 2005
    ..These findings always have to be interpreted in the context of the clinical features and biologic behavior...
  9. ncbi request reprint CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype
    Mirjana Urosevic
    Department of Dermatology, University Hospital Zurich, Zurich 8091, Switzerland
    Hum Pathol 36:1020-4. 2005
    ..MxA protein, representing the surrogate marker for lesional type I interferon activity, was expressed in 4 of 5 evaluated cases. Our findings further substantiate the putative pDC origin of CD4+CD56+ HNs...
  10. ncbi request reprint Granulomatous slack skin responds to UVA1 phototherapy
    Patrick A Oberholzer
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Dermatology 219:268-71. 2009
    ..A follow-up 12 months after phototherapy showed continued treatment benefit. To our knowledge, this is the first report describing the successful use of UVA1 (340-400 nm) phototherapy in a patient with GSS...
  11. doi request reprint Cutaneous lymphomas: molecular pathways leading to new drugs
    Reinhard Dummer
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    J Invest Dermatol 132:517-25. 2012
    ..The rational and well-coordinated application of these tools, together with improved chemotherapeutic options, will hopefully further improve treatment success in the near future...
  12. doi request reprint Spindle-cell variant of primary cutaneous follicle center lymphoma spreading to the hepatobiliary tree, mimicking Klatskin tumor
    Sima Rozati
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    J Cutan Pathol 40:56-60. 2013
    ..On the basis of the sparse published data on spindle-cell morphology of pcBCL, this growth pattern should elicit awareness of an increased risk of systemic involvement in the otherwise indolent pcFCL...
  13. ncbi request reprint [Perspective of cutaneous lymphoma reserach]
    Reinhard Dummer
    Dermatologische Klinik, Universitatsspital Zurich, Schweiz
    J Dtsch Dermatol Ges 4:492-5. 2006
    ..The new WHO/EORTC classification definitely will facilitate a more detailed investigation of the various subtypes...
  14. ncbi request reprint Oral, esophageal and cutaneous lichen ruber planus controlled with alitretinoin: case report and review of the literature
    Antonios G A Kolios
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Dermatology 226:302-10. 2013
    ..Therapy-resistant lichen planus (LP) can be a challenging condition for dermatologists. There are some case reports about successful treatments with alitretinoin of cutaneous and oral, but not of esophageal LP...
  15. doi request reprint Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification
    Werner Kempf
    Kempf und Pfaltz Histologische Diagnostik, Zurich, Switzerland
    Am J Dermatopathol 35:159-66. 2013
    ....
  16. doi request reprint Primary cutaneous B-cell lymphomas
    Werner Kempf
    Department of Dermatology, University Hospital Zurich, Switzerland
    J Dtsch Dermatol Ges 10:12-22; quiz 23. 2012
    ..Clinico-pathologic correlation, histology with immunohistochemical profile and genotyping as well as staging examinations are crucial diagnostic elements in the work-up of CBCL...
  17. ncbi request reprint Standard and experimental therapy in cutaneous T-cell lymphomas
    Reinhard Dummer
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    J Cutan Pathol 33:52-7. 2006
    ..Evidence-based treatment recommendation exists but is hampered by the lack of large multicenter randomized trials...
  18. ncbi request reprint Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors
    Michel Gilliet
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Arch Dermatol 140:1490-5. 2004
    ..It has been proposed that the innate immune system plays a central role in driving the autoimmune T-cell cascade leading to psoriasis; however, there is no direct evidence for this...
  19. doi request reprint Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome
    Joanna Mangana
    Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich, Switzerland
    Eur J Dermatol 18:566-70. 2008
    ..Pegylated liposomal doxorubicin induces various skin reactions including palmoplantar erythrodysesthesia syndrome. However, the exact clinical presentation might depend on pre-existing skin diseases...
  20. doi request reprint Prevalence of Merkel cell polyomavirus among Swiss Merkel cell carcinoma patients
    Joanna Mangana
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Dermatology 221:184-8. 2010
    ..Recently, the clonal integration of a newly identified polyomavirus called Merkel cell polyomavirus (MCPyV) was reported in up to 80% of MCC tissue. Here we report the incidence rate of MCPyV in MCC patients in Switzerland...
  21. doi request reprint Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
    Emmanuella Guenova
    University Hospital of Zurich, Department of Dermatology, Gloriastrasse 31, 8091 Zurich, Switzerland 41 44 255 5528
    Expert Opin Investig Drugs 23:457-67. 2014
    ..Standard therapeutic approaches are well established and often achieve stable disease. However, cure for MF is rare and thus novel therapies are needed...
  22. doi request reprint T cell-mediated acute localized exanthematous pustulosis caused by finasteride
    Sandra Tresch
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    J Allergy Clin Immunol 129:589-94. 2012
    ..Within 4 weeks after withdrawal of finasteride, the rash resolved without any specific therapy. Transient discrete residual hyperpigmentation and scaling were present. The patient refused an oral provocation challenge...
  23. pmc EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
    Werner Kempf
    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
    Blood 118:4024-35. 2011
    ..The recommendations represent the state-of-the-art management of CD30(+) LPDs and include definitions for clinical endpoints as well as response criteria for future clinical trials in CD30(+) LPDs...
  24. doi request reprint Internet based health promotion campaign against skin cancer - Results of www.skincheck.ch in Switzerland
    Marjam Jeanette Barysch
    Department of Dermatology, University Hospital of Zurich, CH 8091 Zurich, Switzerland
    Eur J Dermatol 20:109-14. 2010
    ..We conclude that internet-based, interactive, educational programs, in addition to existing health promotion campaigns, can enhance public participation in the middle aged male population in skin cancer prevention...
  25. doi request reprint T-cell clonality assays: how do they compare?
    Antonio Cozzio
    Department of Dermatology, Zurich University Hospital, Zurich, Swizerland
    J Invest Dermatol 128:771-3. 2008
    ..The resulting genetic heterogeneity may ultimately lead to subclones in the formerly monoclonal population of tumor cells...
  26. pmc Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors
    Antonio Cozzio
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Genes Dev 17:3029-35. 2003
    ....
  27. ncbi request reprint MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice
    Chi Wai So
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Cancer Cell 3:161-71. 2003
    ..This experimental modeling of ABL in mice highlights its origin from multipotential progenitors that arrest at a bipotential stage specifically targeted or induced by MLL oncogenes...
  28. pmc Varicella-zoster virus infection of human neural cells in vivo
    Armin Baiker
    Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 101:10792-7. 2004
    ..The chimeric nonobese diabetic severe combined immunodeficient mouse model may be useful for investigating other neurotropic human viruses...
  29. pmc Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo
    Holger Karsunky
    Institute for Research in Biomedicine IRB, Via Vincenzo Vela 6, CH 6500 Bellinzona, Switzerland
    J Exp Med 198:305-13. 2003
    ....